Literature DB >> 22287689

Hereditary colorectal cancer diagnostics: morphological features of familial colorectal cancer type X versus Lynch syndrome.

Louise Klarskov1, Susanne Holck, Inge Bernstein, Mef Nilbert.   

Abstract

BACKGROUND: The hereditary non-polyposis colorectal cancer (HNPCC) subset of tumours can broadly be divided into tumours caused by an underlying mismatch-repair gene mutation, referred to as Lynch syndrome, and those that develop in families with similar patterns of heredity but without disease-predisposing germline mismatch repair mutations, referred to as familial colorectal cancer type X (FCCTX). Recognition of HNPCC-associated colorectal cancers is central since surveillance programmes effectively reduce morbidity and mortality. The characteristic morphological features linked to Lynch syndrome can aid in the identification of this subset, whereas the possibility to use morphological features as an indicator of FCCTX is uncertain. OBJECTIVE AND METHODS: To perform a detailed morphological evaluation of HNPCC-associated colorectal cancers and demonstrate significant differences between tumours associated with FCCTX and Lynch syndrome.
RESULTS: The morphological features associated with Lynch syndrome, that is, right-sided tumour location, poor differentiation, expansive growth pattern, tumour-infiltrating lymphocytes, peritumorous lymphocytes, Crohn-like reactions, and lack of dirty necrosis, were significantly less often observed in FCCTX tumours. DISCUSSION: The less typical morphology in FCCTX implies that family history of cancer needs to be taken into account since these tumours cannot readily be recognised based on histopathological features.

Entities:  

Mesh:

Year:  2012        PMID: 22287689     DOI: 10.1136/jclinpath-2011-200535

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  15 in total

Review 1.  Familial colorectal cancer type X: genetic profiles and phenotypic features.

Authors:  Mev Dominguez-Valentin; Christina Therkildsen; Sabrina Da Silva; Mef Nilbert
Journal:  Mod Pathol       Date:  2014-04-18       Impact factor: 7.842

Review 2.  Molecular approach to genetic and epigenetic pathogenesis of early-onset colorectal cancer.

Authors:  Gulcin Tezcan; Berrin Tunca; Secil Ak; Gulsah Cecener; Unal Egeli
Journal:  World J Gastrointest Oncol       Date:  2016-01-15

3.  [A 44-year-old woman with hereditary nonpolyposis colon carcinoma: screening examinations for non-colonic tumors].

Authors:  J Holzhüter; T Rösch; A Block; A W Lohse; S Lüth
Journal:  Internist (Berl)       Date:  2013-03       Impact factor: 0.743

4.  Cancer risk and overall survival in mismatch repair proficient hereditary non-polyposis colorectal cancer, Lynch syndrome and sporadic colorectal cancer.

Authors:  Pilar Garre; Lorena Martín; Inmaculada Bando; Alicia Tosar; Patricia Llovet; Julián Sanz; Atocha Romero; Miguel de la Hoya; Eduardo Díaz-Rubio; Trinidad Caldés
Journal:  Fam Cancer       Date:  2014-03       Impact factor: 2.375

Review 5.  Familial colon cancer syndromes: an update of a rapidly evolving field.

Authors:  Swati G Patel; Dennis J Ahnen
Journal:  Curr Gastroenterol Rep       Date:  2012-10

6.  Distinct gene expression signatures in lynch syndrome and familial colorectal cancer type x.

Authors:  Mev Dominguez-Valentin; Christina Therkildsen; Srinivas Veerla; Mats Jönsson; Inge Bernstein; Ake Borg; Mef Nilbert
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

Review 7.  The tumor border configuration of colorectal cancer as a histomorphological prognostic indicator.

Authors:  Viktor H Koelzer; Alessandro Lugli
Journal:  Front Oncol       Date:  2014-02-18       Impact factor: 6.244

8.  DNA Methylation Identifies Loci Distinguishing Hereditary Nonpolyposis Colorectal Cancer Without Germ-Line MLH1/MSH2 Mutation from Sporadic Colorectal Cancer.

Authors:  Chung-Hsing Chen; Shih Sheng Jiang; Ling-Ling Hsieh; Reiping Tang; Chao A Hsiung; Hui-Ju Tsai; I-Shou Chang
Journal:  Clin Transl Gastroenterol       Date:  2016-12-15       Impact factor: 4.488

9.  Differential expression of CK20, β-catenin, and MUC2/5AC/6 in Lynch syndrome and familial colorectal cancer type X.

Authors:  Stefan Haraldsson; Louise Klarskov; Mef Nilbert; Inge Bernstein; Jesper Bonde; Susanne Holck
Journal:  BMC Clin Pathol       Date:  2017-08-17

10.  Characterisation of familial colorectal cancer Type X, Lynch syndrome, and non-familial colorectal cancer.

Authors:  S Shiovitz; W K Copeland; M N Passarelli; A N Burnett-Hartman; W M Grady; J D Potter; S Gallinger; D D Buchanan; C Rosty; A K Win; M Jenkins; S N Thibodeau; R Haile; J A Baron; L L Marchand; P A Newcomb; N M Lindor
Journal:  Br J Cancer       Date:  2014-06-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.